19018-Lung Cancer-NA-1517

Lung Cancer

516-005: A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy (SAPPHIRE)

  • Details

ClinicalTrials.gov ID: NCT03906071
Diagnosis Type: NA
USOR Number: 19018

  • Address

5236 W University Dr, Suite 1000
McKinney, TX 75071
P: (972) 542-8609

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.